Utah Medical Products
UTMD
#7719
Rank
S$0.30 B
Marketcap
$90.04
Share price
1.01%
Change (1 day)
-16.40%
Change (1 year)
Categories

P/E ratio for Utah Medical Products (UTMD)

P/E ratio as of November 2024 (TTM): 14.7

According to Utah Medical Products's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 14.677. At the end of 2022 the company had a P/E ratio of 22.2.

P/E ratio history for Utah Medical Products from 2001 to 2023

PE ratio at the end of each year

Year P/E ratio Change
202222.2-10.29%
202124.7-11.85%
202028.02.55%
201927.463.43%
201816.7-53.25%
201735.859.03%
201622.521.01%
201518.6-6.57%
201419.95.3%
201318.944.84%
201213.1-1.41%
201113.2-18.29%
201016.2-4.99%
200917.145.31%
200811.7-20.61%
200714.8-7.19%
200615.9-4.75%
200516.771.97%
20049.7370.8%
20035.69-56.47%
200213.112.46%
200111.6

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
59.3 304.26%๐Ÿ‡บ๐Ÿ‡ธ USA
18.7 27.50%๐Ÿ‡บ๐Ÿ‡ธ USA
22.7 54.66%๐Ÿ‡บ๐Ÿ‡ธ USA
11.1-24.52%๐Ÿ‡บ๐Ÿ‡ธ USA
39.2 166.74%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.